Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Ligand Binding Sites02:40

Ligand Binding Sites

6.0K
6.0K
Ligand Binding Sites02:40

Ligand Binding Sites

11.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Protein Organization01:24

Protein Organization

7.2K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
7.2K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

2.1K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-resident immune cells in tumors: Cytokine-mediated regulation, functional plasticity, and therapeutic opportunities.

Cytokine & growth factor reviews·2026
Same author

Augmented BindingNet dataset for enhanced ligand binding pose predictions using deep learning.

npj drug discovery·2026
Same author

Development and preliminary validation of a WeChat-based auditory-speech rehabilitation system for Mandarin-speaking cochlear implant users.

Digital health·2026
Same author

The role of macrophage-myofibroblast transition in the pathogenesis of multi-organ fibrosis.

Tissue & cell·2026
Same author

Block sparse Bayesian learning with environmental perturbation for robust matched field processing.

The Journal of the Acoustical Society of America·2026
Same author

DS-MTNet: A dual-stream multi-task network for histopathology localization and histologic risk stratification from small biopsy specimens of bladder cancer.

Computer methods and programs in biomedicine·2026

Related Experiment Video

Updated: May 6, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K

[Computational chemistry in structure-based drug design].

Ran Cao1, Wei Li, Han-Zi Sun

  • 1National Institute of Biological Sciences Beijing, Beijing 102206, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|October 19, 2013
PubMed
Summary
This summary is machine-generated.

Computational chemistry accelerates drug discovery by enabling accurate ligand binding free-energy calculations. This review highlights new methods and applications in structure-based drug design, addressing current challenges.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

1.8K

Related Experiment Videos

Last Updated: May 6, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

1.8K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Structural biology

Background:

  • Rapid advancements in understanding biological targets' sequence and structure.
  • Interdisciplinary contributions from physics and computational science to biology and drug discovery.
  • Challenges in rationally designing small molecular ligands based on target structures.

Purpose of the Study:

  • To review newly developed computational chemistry methods for structure-based drug design.
  • To highlight applications such as binding-site druggability assessment, virtual screening, and lead optimization.
  • To address current bottlenecks and propose solutions in the field.

Main Methods:

  • Physics-based computational chemistry approaches.
  • Algorithm development.
  • Analysis of computational methods in drug design.

Main Results:

  • Increased role of computational chemistry in structure-based drug design.
  • Successful applications in binding-site druggability assessment.
  • Effective large-scale virtual screening and lead compound optimization.

Conclusions:

  • Computational chemistry is crucial for accurate ligand binding free-energy calculations.
  • New methods enhance structure-based drug design capabilities.
  • Addressing current bottlenecks will further advance drug discovery.